{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:04:02Z","timestamp":1772751842345,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00428-018-2468-0","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T03:52:51Z","timestamp":1539834771000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma"],"prefix":"10.1007","volume":"474","author":[{"given":"Marie-Lisa","family":"Eich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline C.","family":"Tregnago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila F.","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen N.","family":"Palsgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephania M.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Munari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alcides","family":"Chaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-9134","authenticated-orcid":false,"given":"George J.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"2468_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2011) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int 107:1059\u20131064. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09675.x","journal-title":"BJU Int"},{"key":"2468_CR2","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","volume":"104","author":"P Colin","year":"2009","unstructured":"Colin P, Koenig P, Ouzzane A et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104:1436\u20131440. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08838.x","journal-title":"BJU Int"},{"key":"2468_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.urology.2005.01.019","volume":"65","author":"M Roupr\u00eat","year":"2005","unstructured":"Roupr\u00eat M, Fromont G, Azzouzi A-R et al (2005) Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 65:1233\u20131237. \n                    https:\/\/doi.org\/10.1016\/j.urology.2005.01.019","journal-title":"Urology"},{"key":"2468_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","volume":"189","author":"DA Green","year":"2013","unstructured":"Green DA, Rink M, Xylinas E et al (2013) Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol 189:1214\u20131221. \n                    https:\/\/doi.org\/10.1016\/j.juro.2012.05.079","journal-title":"J Urol"},{"key":"2468_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","volume":"72","author":"TJ Moss","year":"2017","unstructured":"Moss TJ, Qi Y, Xi L et al (2017) Comprehensive genomic characterization of upper tract urothelial carcinoma. Eur Urol 72:641\u2013649. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.05.048","journal-title":"Eur Urol"},{"key":"2468_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1517\/14728222.9.4.753","volume":"9","author":"R Baserga","year":"2005","unstructured":"Baserga R (2005) The insulin-like growth factor-I receptor as a target for cancer therapy. Expert Opin Ther Targets 9:753\u2013768. \n                    https:\/\/doi.org\/10.1517\/14728222.9.4.753","journal-title":"Expert Opin Ther Targets"},{"key":"2468_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ncponc0934","volume":"4","author":"Y Tao","year":"2007","unstructured":"Tao Y, Pinzi V, Bourhis J, Deutsch E (2007) Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway\u2014therapeutic perspectives in cancer. Nat Clin Pract Oncol 4:591\u2013602. \n                    https:\/\/doi.org\/10.1038\/ncponc0934","journal-title":"Nat Clin Pract Oncol"},{"key":"2468_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cllc.2011.10.006","volume":"13","author":"M Nakagawa","year":"2012","unstructured":"Nakagawa M, Uramoto H, Oka S et al (2012) Clinical significance of IGF1R expression in non-small-cell lung cancer. Clin Lung Cancer 13:136\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.cllc.2011.10.006","journal-title":"Clin Lung Cancer"},{"key":"2468_CR9","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-08-2755","volume":"68","author":"JH Law","year":"2008","unstructured":"Law JH, Habibi G, Hu K et al (2008) Phosphorylated insulin-like growth factor-i\/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res 68:10238\u201310246. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2755","journal-title":"Cancer Res"},{"key":"2468_CR10","first-page":"2942","volume":"62","author":"GO Hellawell","year":"2002","unstructured":"Hellawell GO, Turner GDH, Davies DR et al (2002) Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res 62:2942\u20132950","journal-title":"Cancer Res"},{"key":"2468_CR11","doi-asserted-by":"publisher","first-page":"1444.e1","DOI":"10.1016\/j.urology.2014.01.028","volume":"83","author":"N Gonzalez-Roibon","year":"2014","unstructured":"Gonzalez-Roibon N, Kim JJ, Faraj SF et al (2014) Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy. Urology 83:1444.e1\u20131444.e6. \n                    https:\/\/doi.org\/10.1016\/j.urology.2014.01.028","journal-title":"Urology"},{"key":"2468_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0046-8177(03)00291-0","volume":"34","author":"A Ouban","year":"2003","unstructured":"Ouban A, Muraca P, Yeatman T, Coppola D (2003) Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum Pathol 34:803\u2013808","journal-title":"Hum Pathol"},{"key":"2468_CR13","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/j.1464-410X.2007.06931.x","volume":"100","author":"MA Rochester","year":"2007","unstructured":"Rochester MA, Patel N, Turney BW et al (2007) The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer. BJU Int 100:1396\u20131401. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2007.06931.x","journal-title":"BJU Int"},{"key":"2468_CR14","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours of the urinary system and male genital organs, 4th ed. International Agency for Research on Cancer (IARC), Lyon"},{"key":"2468_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene F et al (2017) AJCC cancer staging manual, 8th edn. Springer International Publishing, New York","edition":"8"},{"key":"2468_CR16","first-page":"89","volume":"103","author":"HL Fedor","year":"2005","unstructured":"Fedor HL, De Marzo AM (2005) Practical methods for tissue microarray construction. Methods Mol Med 103:89\u2013101","journal-title":"Methods Mol Med"},{"key":"2468_CR17","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1200\/JCO.2011.35.2245","volume":"29","author":"ME Hammond","year":"2011","unstructured":"Hammond ME, Hayes DF, Wolff AC (2011) Clinical notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER\/PgR and HER2 testing in breast cancer. J Clin Oncol 29:e458. \n                    https:\/\/doi.org\/10.1200\/JCO.2011.35.2245","journal-title":"J Clin Oncol"},{"key":"2468_CR18","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/cncr.22677","volume":"109","author":"AJ Pantuck","year":"2007","unstructured":"Pantuck AJ, Seligson DB, Klatte T et al (2007) Prognostic relevance of the mTOR pathway in renal cell carcinoma. Cancer 109:2257\u20132267. \n                    https:\/\/doi.org\/10.1002\/cncr.22677","journal-title":"Cancer"},{"key":"2468_CR19","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.4161\/cbt.8.24.9987","volume":"8","author":"JJ Mansure","year":"2009","unstructured":"Mansure JJ, Nassim R, Chevalier S et al (2009) Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer. Cancer Biol Ther 8:2339\u20132347","journal-title":"Cancer Biol Ther"},{"key":"2468_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/mc.20420","volume":"47","author":"LD Harris","year":"2008","unstructured":"Harris LD, De La Cerda J, Tuziak T et al (2008) Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray. Mol Carcinog 47:678\u2013685. \n                    https:\/\/doi.org\/10.1002\/mc.20420","journal-title":"Mol Carcinog"},{"key":"2468_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10555-013-9482-0","volume":"33","author":"J Wu","year":"2014","unstructured":"Wu J, Yu E (2014) Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy. Cancer Metastasis Rev 33:607\u2013617. \n                    https:\/\/doi.org\/10.1007\/s10555-013-9482-0","journal-title":"Cancer Metastasis Rev"},{"key":"2468_CR22","doi-asserted-by":"publisher","first-page":"538019","DOI":"10.1155\/2015\/538019","volume":"2015","author":"VP Brahmkhatri","year":"2015","unstructured":"Brahmkhatri VP, Prasanna C, Atreya HS (2015) Insulin-like growth factor system in cancer: novel targeted therapies. Biomed Res Int 2015:538019. \n                    https:\/\/doi.org\/10.1155\/2015\/538019","journal-title":"Biomed Res Int"},{"key":"2468_CR23","first-page":"637","volume":"29","author":"E Gkioka","year":"2015","unstructured":"Gkioka E, Msaouel P, Philippou A et al (2015) Review: the role of insulin-like growth factor-1 signaling pathways in uterine leiomyoma. In Vivo 29:637\u2013649","journal-title":"In Vivo"},{"key":"2468_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/bcr50","volume":"2","author":"X Zhang","year":"2000","unstructured":"Zhang X, Yee D (2000) Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. Breast Cancer Res 2:170\u2013175","journal-title":"Breast Cancer Res"},{"key":"2468_CR25","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/jcp.24323","volume":"228","author":"HL Goel","year":"2013","unstructured":"Goel HL, Sayeed A, Breen M et al (2013) \u03b21 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1. J Cell Physiol 228:1601\u20131609. \n                    https:\/\/doi.org\/10.1002\/jcp.24323","journal-title":"J Cell Physiol"},{"key":"2468_CR26","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.2741\/2925","volume":"13","author":"AJ Casa","year":"2008","unstructured":"Casa AJ, Dearth RK, Litzenburger BC et al (2008) The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance. Front Biosci 13:3273\u20133287","journal-title":"Front Biosci"},{"key":"2468_CR27","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1016\/j.humpath.2013.07.008","volume":"44","author":"E Munari","year":"2013","unstructured":"Munari E, Fujita K, Faraj S et al (2013) Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma. Hum Pathol 44:2668\u20132676. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2013.07.008","journal-title":"Hum Pathol"},{"key":"2468_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.urology.2009.07.1296","volume":"75","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G, Jeldres C, Isbarn H et al (2010) A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 75:118\u2013124. \n                    https:\/\/doi.org\/10.1016\/j.urology.2009.07.1296","journal-title":"Urology"},{"key":"2468_CR29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","volume":"57","author":"G Novara","year":"2010","unstructured":"Novara G, Matsumoto K, Kassouf W et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57:1064\u20131071. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2009.12.029","journal-title":"Eur Urol"},{"key":"2468_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1530\/ERC-10-0046","volume":"18","author":"SC Drury","year":"2011","unstructured":"Drury SC, Detre S, Leary A et al (2011) Changes in breast cancer biomarkers in the IGF1R\/PI3K pathway in recurrent breast cancer after tamoxifen treatment. Endocr Relat Cancer 18:565\u2013577. \n                    https:\/\/doi.org\/10.1530\/ERC-10-0046","journal-title":"Endocr Relat Cancer"},{"key":"2468_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1471-2407-9-165","volume":"9","author":"G Turashvili","year":"2009","unstructured":"Turashvili G, Leung S, Turbin D et al (2009) Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situhybridization (FISH): pathologist assessment compared to quantitative image analysis. BMC Cancer 9:165. \n                    https:\/\/doi.org\/10.1186\/1471-2407-9-165","journal-title":"BMC Cancer"},{"key":"2468_CR32","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/j.ejca.2006.06.020","volume":"42","author":"M Lacroix-Triki","year":"2006","unstructured":"Lacroix-Triki M, Mathoulin-Pelissier S, Ghnassia J-P et al (2006) High inter-observer agreement in immunohistochemical evaluation of HER-2\/neu expression in breast cancer: a multicentre GEFPICS study. Eur J Cancer 42:2946\u20132953. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2006.06.020","journal-title":"Eur J Cancer"},{"key":"2468_CR33","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1200\/JCO.2008.17.3567","volume":"26","author":"RL Camp","year":"2008","unstructured":"Camp RL, Neumeister V, Rimm DL (2008) A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol 26:5630\u20135637. \n                    https:\/\/doi.org\/10.1200\/JCO.2008.17.3567","journal-title":"J Clin Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-018-2468-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2468-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2468-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T19:24:05Z","timestamp":1571340245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-018-2468-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2468"],"URL":"https:\/\/doi.org\/10.1007\/s00428-018-2468-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"assertion":[{"value":"16 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all the patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}